Dov

For Antidepressants, Maybe Three Targets Will Be Better than Two
WSJ Online
Tue, 02/10/09 - 07:07 am
antidepressants
TRIs
Neurosearch
AstraZeneca
Bristol-Myers Squibb
Dov